Varying presentations of immune checkpoint inhibitor-associated myocarditis: A case report of the clinical characteristics and outcomes of three patients

• DOI: 10.1016/j.gore.2023.101271
• Publication Date: 2023-09-15T10:02:31Z
• Authors: Brandon Fox; Floor Backes
• Keywords: RG1-991; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; Case Report; Gynecology and obstetrics; RC254-282

•ICI-associated myocarditis is a rare clinical entity, but one with an exceedingly high mortality rate.•The condition can present wide variety of manifestations. Thus, suspicion for the diagnosis should remain elevated in at-risk patients receiving immunotherapy.•Early and prompt initiation high-dose steroids are key to optimizing patient outcomes.